Abstract | AIM: Plasma asymmetric dimethylarginine (ADMA) is a novel risk factor for atherosclerosis and has been observed to associate with endothelial function in cross-section studies. In the present study our aim was to investigate whether plasma ADMA levels are predictive of brachial artery endothelial function in a prospective setting. METHODS AND RESULTS: Using ultrasound we measured brachial artery flow-mediated dilation (FMD) both in 2001 and 2007 in 1808 healthy subjects aged 24-39 years at baseline. Plasma methylarginines were determined by isocratic high-pressure liquid chromatography in 2001. In a multivariable model adjusted with brachial diameter and conventional cardiovascular risk factors, baseline ADMA levels had a significant inverse association with FMD measured 6 years later (β±SE: -1.89±0.69%, P=0.006). CONCLUSIONS: We conclude that plasma ADMA can predict brachial artery FMD in subjects without prevalent atherosclerotic disease. These data suggest that plasma ADMA may have a determinative role in predicting endothelial function.
|
Authors | Hannu Päivä, Mika Kähönen, Terho Lehtimäki, Georg Alfthan, Jorma Viikari, Reijo Laaksonen, Nina Hutri-Kähönen, Tomi Laitinen, Leena Taittonen, Olli T Raitakari, Markus Juonala |
Journal | Atherosclerosis
(Atherosclerosis)
Vol. 212
Issue 2
Pg. 512-5
(Oct 2010)
ISSN: 1879-1484 [Electronic] Ireland |
PMID | 20655043
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- N,N-dimethylarginine
- Arginine
|
Topics |
- Adult
- Arginine
(analogs & derivatives, biosynthesis)
- Brachial Artery
(pathology)
- Cardiovascular Diseases
(diagnosis, epidemiology)
- Chromatography, High Pressure Liquid
(methods)
- Cohort Studies
- Endothelium, Vascular
(cytology)
- Female
- Finland
- Humans
- Male
- Middle Aged
- Multivariate Analysis
- Risk Factors
|